Association between inflammatory biomarkers and depressive symptoms among diabetes mellitus and diabetic retinopathy: A cross-sectional study
Open Access
- 15 May 2026
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (20) , e48915
Abstract
This study aimed to compare patients with diabetes mellitus (DM) and diabetic retinopathy (DR), analyze the relationship between inflammatory biomarkers and depressive symptoms, and further explore the role path of weight management. Data were attained from National Health And Nutrition Examination Survey 2011 to 2020. We calculated the neutrophils-lymphocytes ratio (NLR), systemic inflammatory response index (SIRI), aggregate index of systemic inflammation (AISI) and systemic immune inflammation index (SII). A generalized linear model was used to examine the influence of NLR, SIRI, AISI, and SII on depressive symptoms among DM and DR and the influence of body mass index (BMI) and waist circumference (WC) on depressive symptoms among DR. The mediation effect model was employed to examine the relationship between inflammatory biomarkers, BMI, WC and Patient Health Questionnaire-9 scores among DM. Among 2584 participants with diabetes, 2069 (80.07%) were without retinopathy and 515 (19.93%) were diagnosed with DR, NLR, SIRI, AISI, and SII were risk factors for depressive symptoms among DM (odds ratio [OR] = 1.236, 95% confidence interval [CI] = 1.080–1.415, P = .002; OR = 1.369, 95% CI = 1.155–1.623, P < .001; OR = 1.001, 95% CI = 1.000–1.002, P < .001; OR = 1.001, 95% CI = 1.000–1.001, P = .003). WC fully mediated the relationship between NLR and Patient Health Questionnaire-9 among adults with DM, with effect coefficients of 0.028 (95% CI = 0.005–0.059). BMI and WC were risk factors for depressive symptoms among DR (OR = 1.115, 95% CI = 1.043–1.192, P = .001; OR = 1.044, 95% CI = 1.014–1.074, P = .004). Inflammatory biomarkers are the risk factors of depressive symptoms only in adults with DM, but not in DR. Among adults with DM, we should pay attention to monitoring the level of inflammation and reduce WC instead of BMI, while in DR patients, controlling BMI and WC is an effective strategy to prevent and control depressive symptoms.Keywords
Funding Information
- Tianjin Key Medical Discipline (Specialty) Construction Project (TJYXZDXK-037A)
This publication has 41 references indexed in Scilit:
- Serum inflammation biomarkers level in cystoid and diffuse diabetic macular edemaInternational Ophthalmology, 2024
- Inflammatory Biomarkers and Risk of Psychiatric DisordersJAMA Psychiatry, 2024
- Current research and future strategies for the management of vision-threatening diabetic retinopathyAsia-Pacific Journal of Ophthalmology, 2024
- Depression in Individuals With Diabetic Retinopathy in the US National Health and Nutrition Examination Survey, 2005-2008American Journal of Ophthalmology, 2023
- IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045Diabetes Research and Clinical Practice, 2022
- Using the 9-Item Patient Health Questionnaire to Screen for and Monitor DepressionJAMA, 2019
- Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th editionDiabetes Research and Clinical Practice, 2019
- Measurement invariance of the patient health questionnaire‐9 (PHQ‐9) depression screener in U.S. adults across sex, race/ethnicity, and education level: NHANES 2005–2016Depression and Anxiety, 2019
- Association Between Diabetes-Related Eye Complications and Symptoms of Anxiety and DepressionJAMA Ophthalmology, 2016
- Is Obesity Related to Microvascular and Macrovascular Complications in Diabetes?Archives of internal medicine (1960), 1997